Predicting recovery of myocardial function by electrocardiography after acute infarction

Ann Noninvasive Electrocardiol. 2013 May;18(3):230-9. doi: 10.1111/anec.12015. Epub 2012 Nov 22.

Abstract

Background: In acute ischemic left ventricular (LV) dysfunction, distinguishing viable myocardium is clinically important.

Methods: Body surface potential mapping (Electrocardiography [ECG] with 123 leads), was recorded in 62 patients with acute coronary syndrome (ACS). ECG variables were computed from de- and repolarization phases. LV segmental wall motion was assessed by echocardiography acutely and after 1 year.

Results: The number of dysfunctional segments (DFS) diminished during follow-up in 37 patients (recovery group) and remained the same or increased in 25 patients (nonrecovery group). Acutely, DFS was 5.7 ± 2.1 versus 4.4 ± 2.4 (P = 0.02), and peak CK-MBm 141 ± 157 versus 156 ± 167 μg/L (P = 0.78) in the recovery versus nonrecovery group. At follow-up, DFS was 1.9 ± 1.7 versus 6.5 ± 2.6 (P < 0.001). The best ECG variable to predict decrease in DFS depended on the region of acute LV dysfunction: The best variable in the left anterior descending region was the integral of the first QRS integral (area under the curve [AUC] 0.82, P = 0.002); in the right coronary artery region, this was the integral of the ST segment (AUC 0.98, P = 0.003); and in the left circumflex region, the area including the ST segment and the T wave (AUC 0.97, P = 0.006).

Conclusions: In ACS patients, computed ECG variables predict recovery of LV function from ischemic myocardial injury, even in the presence of comparable CK-MBm release and LV dysfunction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Body Surface Potential Mapping*
  • Coronary Angiography
  • Coronary Artery Bypass
  • Echocardiography
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / physiopathology*
  • Myocardial Infarction / therapy
  • Percutaneous Coronary Intervention
  • Predictive Value of Tests
  • Recovery of Function*
  • Thrombolytic Therapy